Literature DB >> 20226990

Porphyrias.

Hervé Puy1, Laurent Gouya, Jean-Charles Deybach.   

Abstract

Hereditary porphyrias are a group of eight metabolic disorders of the haem biosynthesis pathway that are characterised by acute neurovisceral symptoms, skin lesions, or both. Every porphyria is caused by abnormal function of a separate enzymatic step, resulting in a specific accumulation of haem precursors. Seven porphyrias are the result of a partial enzyme deficiency, and a gain of function mechanism has been characterised in a new porphyria. Acute porphyrias present with acute attacks, typically consisting of severe abdominal pain, nausea, constipation, confusion, and seizure, and can be life-threatening. Cutaneous porphyrias present with either acute painful photosensitivity or skin fragility and blisters. Rare recessive porphyrias usually manifest in early childhood with either severe cutaneous photosensitivity and chronic haemolysis or chronic neurological symptoms with or without photosensitivity. Porphyrias are still underdiagnosed, but when they are suspected, and dependent on clinical presentation, simple first-line tests can be used to establish the diagnosis in all symptomatic patients. Diagnosis is essential to enable specific treatments to be started as soon as possible. Screening of families to identify presymptomatic carriers is crucial to decrease risk of overt disease of acute porphyrias through counselling about avoidance of potential precipitants. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20226990     DOI: 10.1016/S0140-6736(09)61925-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  174 in total

Review 1.  Heme metabolism and erythropoiesis.

Authors:  Jacky Chung; Caiyong Chen; Barry H Paw
Journal:  Curr Opin Hematol       Date:  2012-05       Impact factor: 3.284

2.  An atypical case of Guillain-Barré syndrome: acute intermittent porphyria.

Authors:  É Cuquemelle; S Ehrmann; K Razazi; J C Deybach; C Brun-Buisson; A W Thille
Journal:  Intensive Care Med       Date:  2012-01-25       Impact factor: 17.440

3.  Acute intermittent porphyria: fatal complications of treatment.

Authors:  P E Stein; M N Badminton; J H Barth; D C Rees; R Sarkany; M F Stewart; T M Cox
Journal:  Clin Med (Lond)       Date:  2012-06       Impact factor: 2.659

Review 4.  Porphyrias at a glance: diagnosis and treatment.

Authors:  Maria Domenica Cappellini; Valentina Brancaleoni; Giovanna Graziadei; Dario Tavazzi; Elena Di Pierro
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

5.  The porphyrias: pathophysiology.

Authors:  Antonello Pietrangelo
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

6.  Audit of the Use of Regular Haem Arginate Infusions in Patients with Acute Porphyria to Prevent Recurrent Symptoms.

Authors:  Joanne T Marsden; Simon Guppy; Penelope Stein; Timothy M Cox; Michael Badminton; Tricia Gardiner; Julian H Barth; M Felicity Stewart; David C Rees
Journal:  JIMD Rep       Date:  2015-03-12

7.  Mass-spectrometric profiling of porphyrins in complex biological samples with fundamental, toxicological, and pharmacological applications.

Authors:  Sarah A Sullivan; Bennett R Streit; Ethan L Ferguson; Paul A Jean; Debra A McNett; Louis T Llames; Jennifer L DuBois
Journal:  Anal Biochem       Date:  2015-03-10       Impact factor: 3.365

Review 8.  Lamins and Lamin-Associated Proteins in Gastrointestinal Health and Disease.

Authors:  Graham F Brady; Raymond Kwan; Juliana Bragazzi Cunha; Jared S Elenbaas; M Bishr Omary
Journal:  Gastroenterology       Date:  2018-03-13       Impact factor: 22.682

Review 9.  Mitochondrial Iron in Human Health and Disease.

Authors:  Diane M Ward; Suzanne M Cloonan
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

10.  Regulation of intracellular heme trafficking revealed by subcellular reporters.

Authors:  Xiaojing Yuan; Nicole Rietzschel; Hanna Kwon; Ana Beatriz Walter Nuno; David A Hanna; John D Phillips; Emma L Raven; Amit R Reddi; Iqbal Hamza
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.